Why Novavax May Extend Its 2,000% Gain

Novavax (NASDAQ: NVAX) surged more than 2,000% last year for the best stock performance -- all industries included. Though it's unlikely to repeat such an increase, there still is plenty of room for share growth. In this Motley Fool Live video recorded on Jan. 22, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss the catalysts ahead for Novavax (NASDAQ: NVAX), which soon will report phase 3 data for its coronavirus vaccine candidate.

 

 

Continue reading

Source Fool.com